Karleigh A. Hamblin

522 total citations
15 papers, 376 citations indexed

About

Karleigh A. Hamblin is a scholar working on Molecular Biology, Genetics and Parasitology. According to data from OpenAlex, Karleigh A. Hamblin has authored 15 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Genetics and 4 papers in Parasitology. Recurrent topics in Karleigh A. Hamblin's work include Bacillus and Francisella bacterial research (6 papers), Bacteriophages and microbial interactions (3 papers) and Yersinia bacterium, plague, ectoparasites research (3 papers). Karleigh A. Hamblin is often cited by papers focused on Bacillus and Francisella bacterial research (6 papers), Bacteriophages and microbial interactions (3 papers) and Yersinia bacterium, plague, ectoparasites research (3 papers). Karleigh A. Hamblin collaborates with scholars based in United Kingdom, Canada and Germany. Karleigh A. Hamblin's co-authors include Helen S. Atkins, Mark van der Giezen, Alexandra Stechmann, Andrew J. Roger, Vicente Pérez‐Brocal, C Graham Clark, Daniel Gaston, Gregory S. Richmond, James Blanchard and Stuart J. Armstrong and has published in prestigious journals such as Biochemistry, Current Biology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Karleigh A. Hamblin

15 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karleigh A. Hamblin United Kingdom 11 181 85 59 58 51 15 376
Rodolfo Hernández‐Gutiérrez Mexico 11 67 0.4× 100 1.2× 38 0.6× 73 1.3× 17 0.3× 33 463
Soheil Sadr Iran 12 79 0.4× 102 1.2× 19 0.3× 26 0.4× 28 0.5× 49 340
Alexey A. Mouzykantov Russia 9 120 0.7× 38 0.4× 43 0.7× 41 0.7× 73 1.4× 28 328
Edeltraud Lüneberg Germany 12 207 1.1× 24 0.3× 95 1.6× 49 0.8× 65 1.3× 18 504
Soledad R. Ordoñez Netherlands 13 167 0.9× 15 0.2× 74 1.3× 93 1.6× 47 0.9× 15 462
Elizabeth Garduño Canada 6 260 1.4× 30 0.4× 29 0.5× 28 0.5× 42 0.8× 9 485
Olga L. Voronina Russia 11 151 0.8× 17 0.2× 52 0.9× 60 1.0× 28 0.5× 65 363
Sebastian Jusuf United States 9 75 0.4× 116 1.4× 21 0.4× 99 1.7× 13 0.3× 15 365
Yoko Kobayashi Japan 8 79 0.4× 23 0.3× 18 0.3× 50 0.9× 17 0.3× 12 312
Fangfang Bai China 13 132 0.7× 17 0.2× 43 0.7× 22 0.4× 61 1.2× 17 409

Countries citing papers authored by Karleigh A. Hamblin

Since Specialization
Citations

This map shows the geographic impact of Karleigh A. Hamblin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karleigh A. Hamblin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karleigh A. Hamblin more than expected).

Fields of papers citing papers by Karleigh A. Hamblin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karleigh A. Hamblin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karleigh A. Hamblin. The network helps show where Karleigh A. Hamblin may publish in the future.

Co-authorship network of co-authors of Karleigh A. Hamblin

This figure shows the co-authorship network connecting the top 25 collaborators of Karleigh A. Hamblin. A scholar is included among the top collaborators of Karleigh A. Hamblin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karleigh A. Hamblin. Karleigh A. Hamblin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Thom, Ruth, Lin Eastaugh, Lyn M. O’Brien, et al.. (2021). Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms. Frontiers in Cellular and Infection Microbiology. 11. 5 indexed citations
2.
Hamblin, Karleigh A., et al.. (2019). ATP-specificity of succinyl-CoA synthetase fromBlastocystis hominis. Acta Crystallographica Section D Structural Biology. 75(7). 647–659. 3 indexed citations
3.
Hamblin, Karleigh A., et al.. (2019). The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With Francisella tularensis Strain SchuS4. Frontiers in Microbiology. 10. 904–904. 7 indexed citations
4.
Hamblin, Karleigh A., Helen C. Flick-Smith, José B. Pereira‐Leal, et al.. (2019). Disulfiram, an alcohol dependence therapy, can inhibit the in vitro growth of Francisella tularensis. International Journal of Antimicrobial Agents. 54(1). 85–88. 12 indexed citations
5.
Tsaousis, Anastasios D., Karleigh A. Hamblin, Luke Young, et al.. (2018). The Human Gut Colonizer Blastocystis Respires Using Complex II and Alternative Oxidase to Buffer Transient Oxygen Fluctuations in the Gut. Frontiers in Cellular and Infection Microbiology. 8. 371–371. 24 indexed citations
6.
Hamblin, Karleigh A., Stuart J. Armstrong, Carwyn Davies, et al.. (2017). Inhaled Liposomal Ciprofloxacin Protects against a Lethal Infection in a Murine Model of Pneumonic Plague. Frontiers in Microbiology. 8. 91–91. 24 indexed citations
7.
Hamblin, Karleigh A., et al.. (2017). Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei. Antimicrobial Agents and Chemotherapy. 61(7). 24 indexed citations
8.
Verma, Sonia, Sunita Gupta, Andrew M. Lynn, et al.. (2016). Engineering Nucleotide Specificity of Succinyl-CoA Synthetase in Blastocystis: The Emerging Role of Gatekeeper Residues. Biochemistry. 56(3). 534–542. 11 indexed citations
9.
Hamblin, Karleigh A., Jonathan P. Wong, James Blanchard, & Helen S. Atkins. (2014). The potential of liposome–encapsulated ciprofloxacin as a tularemia therapy. Frontiers in Cellular and Infection Microbiology. 4. 79–79. 25 indexed citations
10.
Norville, Isobel H., Graham Hatch, Kevin R. Bewley, et al.. (2014). Efficacy of Liposome-Encapsulated Ciprofloxacin in a Murine Model of Q Fever. Antimicrobial Agents and Chemotherapy. 58(9). 5510–5518. 21 indexed citations
11.
Hamblin, Karleigh A., Stuart J. Armstrong, Carwyn Davies, et al.. (2014). Liposome Encapsulation of Ciprofloxacin Improves Protection against Highly Virulent Francisella tularensis Strain Schu S4. Antimicrobial Agents and Chemotherapy. 58(6). 3053–3059. 26 indexed citations
12.
Flick-Smith, Helen C., Marc A. Fox, Karleigh A. Hamblin, et al.. (2013). Assessment of antimicrobial peptide LL-37 as a post-exposure therapy to protect against respiratory tularemia in mice. Peptides. 43. 96–101. 9 indexed citations
13.
Thomas, Rachael, Karleigh A. Hamblin, Stuart J. Armstrong, et al.. (2013). Galleria mellonella as a model system to test the pharmacokinetics and efficacy of antibiotics against Burkholderia pseudomallei. International Journal of Antimicrobial Agents. 41(4). 330–336. 51 indexed citations
14.
Hamblin, Karleigh A., Daron M. Standley, Matthew B. Rogers, et al.. (2008). Localization and nucleotide specificity of Blastocystis succinyl‐CoA synthetase. Molecular Microbiology. 68(6). 1395–1405. 13 indexed citations
15.
Stechmann, Alexandra, Karleigh A. Hamblin, Vicente Pérez‐Brocal, et al.. (2008). Organelles in Blastocystis that Blur the Distinction between Mitochondria and Hydrogenosomes. Current Biology. 18(8). 580–585. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026